Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

4.30
+0.600016.22%
Post-market: 4.300.00000.00%19:45 EDT
Volume:265.23K
Turnover:1.12M
Market Cap:24.89M
PE:1.99
High:4.35
Open:3.83
Low:3.83
Close:3.70
Loading ...
Jan 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2023

Major Issues Report

Form 8-K - Current report
Oct 18, 2023

Major Issues Report

Form 8-K - Current report
Sep 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Major Issues Report

Form 8-K - Current report
Aug 22, 2023

Correspondence

Form CORRESP - Correspondence
Aug 14, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 10, 2023

Major Issues Report

Form 8-K - Current report